Your institution may have access to this item. Find your institution then sign in to continue.
Title
Aneuploidy, <italic>TP53</italic> mutation, and amplification of <italic>MYC</italic> correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.